Spatially confined sub-tumor microenvironments in pancreatic cancer - ScienceDirect
Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer
Hypermutation In Pancreatic Cancer - Gastroenterology
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 4 (2021)
Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma | PLOS ONE
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma | PLOS ONE
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular patholo
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma | Nature Genetics
Emerging molecular markers of cancer | Nature Reviews Cancer
Frontiers | Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer | Scientific Reports
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Frontiers | Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 4 (2021)
The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice - Surgical Pathology Clinics
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications | Gut
Cancer prevention and screening: the next step in the era of precision medicine | npj Precision Oncology
Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer
Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma - ScienceDirect
Cancers | Free Full-Text | Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer | HTML
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study - Annals of Oncology
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers | Science Translational Medicine
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Tar
Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Genes | Free Full-Text | Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer | HTML
Diagnostics | Free Full-Text | The Utility of Endoscopic-Ultrasonography-Guided Tissue Acquisition for Solid Pancreatic Lesions | HTML
